UltraScan™ 650 Bone Densitometer

The only FDA-approved bone sonometer to measure BMD

The UltraScan™ 650 is the first and only FDA-approved bone sonometer that measures bone mineral density (BMD), the most important factor in determining the risk of osteoporotic fracture. Conventional bone sonometers measure parameters like SOS and/or BUA. These parameters have poor correlation with BMD, usually less than 0.8, and thus these devices perform poorly in terms of identifying those individuals with osteoporosis. By contrast, the UltraScan™ 650 uses novel patented net time delay (NTD) technology which allows measurement of the quantity of bone, which in turn provides a direct evaluation of BMD; thus the UltraScan™ 650 is a true "ultrasound bone densitometer". Clinical studies on the UltraScan™ 650 show that its output, BMD_US, is highly correlated (r = 0.93¹) with x-ray based (DXA) measures of BMD. BMD_DXA has‒‒until now that is‒‒been the “gold standard” for bone assessment. Now, with the availability of the UltraScan™ 650, BMD can be measured without the need for DXA, without the ionizing radiation of x-rays, at lower cost and in less time (only 10 seconds). Download a brochure on the UltraScan™ 650, see an ad for the UltraScan™ 650 that has appeared in both Journal for Bone and Mineral Research and Osteoporosis International, watch a 15-second video of a BMD test with the UltraScan™ 650, and Contact Us for more information or to place an order for an UltraScan™ 650, the next generation bone densitometer.

¹It should be noted that the correlation of forearm BMD values as determined by DXA machines from different manufacturers is usually in the range of 0.8 to 0.95.